C3d binding to the myelin oligodendrocyte glycoprotein results in an exacerbated experimental autoimmune encephalomyelitis
- PMID: 17312184
- DOI: 10.4049/jimmunol.178.5.3323
C3d binding to the myelin oligodendrocyte glycoprotein results in an exacerbated experimental autoimmune encephalomyelitis
Abstract
The complement system is known to contribute to demyelination in multiple sclerosis and experimental autoimmune encephalomyelitis. However, there are few data concerning the natural adjuvant effect of C3d on the humoral response when it binds to myelin Ags. This study addresses the effect of C3d binding to the myelin oligodendrocyte glycoprotein (MOG) in the induction of experimental autoimmune encephalomyelitis in C57BL/6J mice. Immunization with human MOG coupled to C3d was found to accelerate the appearance of clinical signs of the disease and to enhance its severity compared with MOG-immunized mice. This finding was correlated with an increased infiltration of leukocytes into the central nervous system accompanied by increased complement activation and associated with areas of demyelination and axonal loss. Furthermore, B cell participation in the pathogenesis of the disease was determined by their increased capacity to act as APCs and to form germinal centers. Consistent with this, the production of MOG-specific Abs was found to be enhanced following MOG/C3d immunization. These results suggest that binding of C3d to self-Ags could increase the severity of an autoimmune disease by enhancing the adaptive autoimmune response.
Similar articles
-
Protective DNA vaccination against myelin oligodendrocyte glycoprotein is overcome by C3d in experimental autoimmune encephalomyelitis.Mol Immunol. 2007 Jul;44(15):3691-701. doi: 10.1016/j.molimm.2007.04.008. Epub 2007 May 22. Mol Immunol. 2007. PMID: 17521729
-
Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).J Mol Neurosci. 2000 Dec;15(3):167-76. doi: 10.1385/JMN:15:3:167. J Mol Neurosci. 2000. PMID: 11303781
-
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.Glia. 2001 Nov;36(2):220-34. doi: 10.1002/glia.1111. Glia. 2001. PMID: 11596130 Review.
-
Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.Exp Mol Pathol. 2008 Aug;85(1):28-39. doi: 10.1016/j.yexmp.2008.03.005. Epub 2008 Apr 8. Exp Mol Pathol. 2008. PMID: 18486939 Free PMC article.
-
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.J Mol Med (Berl). 1997 Feb;75(2):77-88. doi: 10.1007/s001090050092. J Mol Med (Berl). 1997. PMID: 9083925 Review.
Cited by
-
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management.Int J Mol Sci. 2020 Dec 24;22(1):100. doi: 10.3390/ijms22010100. Int J Mol Sci. 2020. PMID: 33374173 Free PMC article. Review.
-
Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.J Neurosci. 2009 Nov 25;29(47):14965-79. doi: 10.1523/JNEUROSCI.3794-09.2009. J Neurosci. 2009. PMID: 19940192 Free PMC article.
-
Star power: harnessing the reactive astrocyte response to promote remyelination in multiple sclerosis.Neural Regen Res. 2024 Mar;19(3):578-582. doi: 10.4103/1673-5374.380879. Neural Regen Res. 2024. PMID: 37721287 Free PMC article. Review.
-
Complement Protein C3 Suppresses Axon Growth and Promotes Neuron Loss.Sci Rep. 2017 Oct 10;7(1):12904. doi: 10.1038/s41598-017-11410-x. Sci Rep. 2017. PMID: 29018286 Free PMC article.
-
Translational insights from EAE models : decoding MOGAD pathogenesis and therapeutic innovation.Front Immunol. 2025 May 20;16:1530977. doi: 10.3389/fimmu.2025.1530977. eCollection 2025. Front Immunol. 2025. PMID: 40463369 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous